Shamaila Munir Ahmad

Medicine & Life Sciences

1. T-Lymphocytes 100%
2. Vaccination 52%
3. Neoplasms 42%
4. Peptides 36%
5. Calreticulin 34%
6. Tumor Microenvironment 29%
7. Vaccines 27%
8. Melanoma 26%
9. Dendritic Cells 22%
10. Indoleamine-Pyrrole 2,3,-Dioxygenase 22%
11. Arginase 21%
12. Epitopes 21%
13. Ligands 16%
14. T-Lymphocyte Epitopes 16%
15. Multiple Myeloma 16%
16. Exons 13%
17. Immunosuppressive Agents 13%
18. staphylococcal alpha-toxin 13%
19. B7-H1 Antigen 12%
20. Tryptophan Oxygenase 12%
21. Cutaneous T-Cell Lymphoma 12%
22. Cancer Vaccines 11%
23. HLA-A2 Antigen 11%
24. HLA Antigens 11%
25. Nivolumab 11%
26. Galectin 3 10%
27. Immunoglobulin Heavy Chains 10%
28. Follicular Lymphoma 10%
29. Apoptosis Regulatory Proteins 9%
30. Mutation 9%
31. Therapeutics 8%
32. B-Cell Chronic Lymphocytic Leukemia 8%
33. Tissue Donors 8%
34. Adaptive Immunity 8%
35. Cytotoxic T-Lymphocytes 8%
36. Cyclophosphamide 7%
37. Blood Cells 7%
38. Interleukin-2 7%
39. Antigens 7%
40. Immune Tolerance 6%
41. Immunity 6%
42. Bone Marrow 5%
43. Regulatory T-Lymphocytes 5%
44. Proteins 5%
45. Immunotherapy 5%
46. Antigen-Presenting Cells 5%
47. Inflammation 5%